-
1
-
-
0001882377
-
The NIDDM epidemic: Global estimates and projections - A look into the crystal ball
-
Zinmet P, McCarty DJ. The NIDDM epidemic: Global estimates and projections - A look into the crystal ball. IDF-bulletin 1995; 40: 8-16
-
(1995)
IDF-bulletin
, vol.40
, pp. 8-16
-
-
Zinmet, P.1
McCarty, D.J.2
-
2
-
-
84862383580
-
Prädiabetes
-
Hasslacher C. Prädiabetes. MMW 2003; 145: 5-21
-
(2003)
MMW
, vol.145
, pp. 5-21
-
-
Hasslacher, C.1
-
3
-
-
0032511120
-
Verbreitung des diabetes mellitus in Deutschland
-
Hauner H. Verbreitung des Diabetes mellitus in Deutschland. Deutsche Medizinische Wochenschrift 1998; 123: 777-782
-
(1998)
Deutsche Medizinische Wochenschrift
, vol.123
, pp. 777-782
-
-
Hauner, H.1
-
6
-
-
0025367559
-
Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?
-
Haffner SM, Stern MB. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 1990; 262: 2893-2898
-
(1990)
JAMA
, vol.262
, pp. 2893-2898
-
-
Haffner, S.M.1
Stern, M.B.2
-
7
-
-
0033998816
-
The impact of diabetes mellitus on survival after myocardial infarction: Can it be modified by drug treatment? Results of a population - Based myocardial infarction register follow-up study
-
Löwel H, Koenig W, Engel S, Hörmann A, Keil U. The impact of diabetes mellitus on survival after myocardial infarction: Can it be modified by drug treatment? Results of a population - based myocardial infarction register follow-up study. Diabetologia 2000; 43: 218-226
-
(2000)
Diabetologia
, vol.43
, pp. 218-226
-
-
Löwel, H.1
Koenig, W.2
Engel, S.3
Hörmann, A.4
Keil, U.5
-
8
-
-
0031460261
-
Efficacy of 24-weak mono-therapy with Acarbose, Metformin or Placebo in dietary-treated NIDDM-patients: The Essen-II-Study
-
Hoffmann J, Spengler M. Efficacy of 24-weak mono-therapy with Acarbose, Metformin or Placebo in dietary-treated NIDDM-patients: The Essen-II-Study. Am J Met 1997; 103: 483-490
-
(1997)
Am J Met
, vol.103
, pp. 483-490
-
-
Hoffmann, J.1
Spengler, M.2
-
9
-
-
0037097039
-
Acarbose for prevention of type 2 diabetes mellitus: The STOP-NIDDM randomised trial
-
Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 2002; 359: 2072-2077
-
(2002)
Lancet
, vol.359
, pp. 2072-2077
-
-
Chiasson, J.L.1
Josse, R.G.2
Gomis, R.3
Hanefeld, M.4
Karasik, A.5
Laakso, M.6
-
11
-
-
0035799806
-
Finnish Diabetes Prevention Study group: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance
-
Tuomilehto J, Lindstrom J, Eriksson JG et al. Finnish Diabetes Prevention Study group: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350
-
(2001)
N Engl J Med
, vol.344
, pp. 1343-1350
-
-
Tuomilehto, J.1
Lindstrom, J.2
Eriksson, J.G.3
-
12
-
-
0030935652
-
Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study
-
Pan XR, Li GW, Hu YH et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997; 20: 537-544
-
(1997)
Diabetes Care
, vol.20
, pp. 537-544
-
-
Pan, X.R.1
Li, G.W.2
Hu, Y.H.3
-
13
-
-
0037034257
-
Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
-
Knowler WC, Barrett-Connor E, Fowler SE et al. Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403
-
(2002)
N Engl J Med
, vol.346
, pp. 393-403
-
-
Knowler, W.C.1
Barrett-Connor, E.2
Fowler, S.E.3
-
16
-
-
84862373908
-
-
Persönliche Mitteilungen des Zentralinstitutes für die kassenärztliche Vereinigung in der Bundesrepublik Deutschland vom 5.9.2003
-
Persönliche Mitteilungen des Zentralinstitutes für die kassenärztliche Vereinigung in der Bundesrepublik Deutschland vom 5.9.2003
-
-
-
-
17
-
-
0033592101
-
Glucosetolerance and mortality: Comparison of WHO and american diabetes association diagnostic criterial
-
The Decode-Study Group on behalf of the European diabetes-epidemiology group. Glucosetolerance and mortality: Comparison of WHO and american diabetes association diagnostic criterial. Lancet 1999; 354: 617-621
-
(1999)
Lancet
, vol.354
, pp. 617-621
-
-
-
18
-
-
84862386733
-
Metabolisches syndrom und makroangiopathie teil I. Bedeutung und diagnostische überlegungen
-
Jacob S, Klimm H-D, Rett K, Augustin HJ, Dietze GJ. Metabolisches Syndrom und Makroangiopathie Teil I. Bedeutung und diagnostische Überlegungen. Perfusion 1995; 8: 339-347
-
(1995)
Perfusion
, vol.8
, pp. 339-347
-
-
Jacob, S.1
Klimm, H.-D.2
Rett, K.3
Augustin, H.J.4
Dietze, G.J.5
-
19
-
-
3042734937
-
Metabolisches syndrom und makroangiopathie teil II. Therapeutische option
-
Jacob S, Klimm H-D, Rett K, Augustin HJ, Dietze GJ. Metabolisches Syndrom und Makroangiopathie Teil II. Therapeutische Option. Perfusion 1995; 8: 360-368
-
(1995)
Perfusion
, vol.8
, pp. 360-368
-
-
Jacob, S.1
Klimm, H.-D.2
Rett, K.3
Augustin, H.J.4
Dietze, G.J.5
|